ViaGen Equine has led the world in the commercialization of somatic cell nuclear transfer for many different species. We have earned the trust of clients around the world including the San Diego Zoo, United States Fish and Wildlife, and thousands of horse and pets clients. Our exclusive licensing of the Roslin Institute SCNT patent portfolio and our ability to effectively commercialize new technology positioned ViaGen Equine as an undisputed world leader in advanced reproduction. Our move into the ICSI field is being prompted by clients and partners who demand that ViaGen Equine apply our proprietary techniques to this growing and important field of advanced reproduction.